BIOAF (Bioasis Technologies) EPS (Diluted): $-0.03 (TTM As of Nov. 2022)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BIOAF Bioasis Technologies Inc BIOAF
12 GF Score
Price $0.00
View Full Analysis

What is Bioasis Technologies EPS (Diluted)?

Bioasis Technologies BIOAF 12 EPS (Diluted) is $-0.03 as of Nov. 2022. GuruFocus rates BIOAF with a GF Score™ of 12/100.

Bioasis Technologies's Earnings per Share (Diluted) for the three months ended in Nov. 2022 was $-0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Nov. 2022 was $-0.03.

Bioasis Technologies's EPS (Basic) for the three months ended in Nov. 2022 was $-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Nov. 2022 was $-0.03.

Bioasis Technologies's EPS without NRI for the three months ended in Nov. 2022 was $-0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Nov. 2022 was $-0.04.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Bioasis Technologies  (OTCPK:BIOAF) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Bioasis Technologies EPS (Diluted) Related Terms

Bioasis Technologies EPS (Diluted) Historical Data

* Premium members only.

The historical data trend for Bioasis Technologies's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioasis Technologies EPS (Diluted) Chart

Bioasis Technologies Annual Data
Trend Feb13 Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.08 -0.05 -0.05 0.01 -0.03

Bioasis Technologies Quarterly Data
Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.01 -0.00 -0.01 -0.01

BIOAF vs VRTX, REGN, SGEN: EPS (Diluted) Comparison

For the Biotechnology subindustry, Bioasis Technologies's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bioasis Technologies PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioasis Technologies's PE Ratio distribution charts can be found below:

* The bar in red indicates where Bioasis Technologies's PE Ratio falls into.


BIOAF
12GF Score
Bioasis Technologies Inc BIOAF
EPS (Diluted) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioasis Technologies EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Bioasis Technologies's Diluted EPS for the fiscal year that ended in Feb. 2022 is calculated as

Diluted EPS (A: Feb. 2022 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-2.329-0)/72.167
=-0.03

Bioasis Technologies's Diluted EPS for the quarter that ended in Nov. 2022 is calculated as

Diluted EPS (Q: Nov. 2022 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-0.733-0)/78.213
=-0.01

EPS (Diluted) for the trailing twelve months (TTM) ended in Nov. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Diluted) →
What does a EPS (Diluted) of $-0.03 mean?
Bioasis Technologies (BIOAF) has a EPS (Diluted) of $-0.03 as of Nov. 2022. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Bioasis Technologies and its competitors.
Is Bioasis Technologies' EPS (Diluted) too high?
Bioasis Technologies' current EPS (Diluted) is $-0.03. Overall, Bioasis Technologies has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bioasis Technologies' EPS (Diluted) compare to VRTX and REGN?
Bioasis Technologies' EPS (Diluted) of $-0.03 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Biotechnology company?
A good EPS (Diluted) depends on the Biotechnology industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Bioasis Technologies and its competitors. Bioasis Technologies's current EPS (Diluted) is $-0.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioasis Technologies stock overvalued right now?
Bioasis Technologies (BIOAF) has a current EPS (Diluted) of $-0.03. The current EPS (Diluted) is $-0.03. Bioasis Technologies' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Bioasis Technologies (BIOAF), the current EPS (Diluted) is $-0.03 as of Nov. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioasis Technologies Business Description

Address 157 Church Street, 19th Floor, New Haven, CT, USA, 06510
Bioasis Technologies Inc is a development stage biopharmaceutical company engaged in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. The company's xB3 program describes its proprietary carrier, p97, and components thereof, to deliver therapeutics across the blood-brain barrier (BBB).
12GF Score

Get the complete analysis for BIOAF

EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price